Ayala Land Best Real Estate Developer in Phl — Euromoney
ALI’s diverse portfolio spans residential, mall, office, hotel, resort and industrial logistics. Projects are spread across 53 estates nationwide.
ALI’s diverse portfolio spans residential, mall, office, hotel, resort and industrial logistics. Projects are spread across 53 estates nationwide.
EVO CITY Whole Development Aerial Artists Perspective.
Ayala Land Inc. (ALI) has been honored by Euromoney, a renowned authority in banking and finance, as the “Best Real Estate Developer in the Philippines.”
“We are honored to receive this prestigious recognition from Euromoney as we execute on Ayala Land’s mission to Enhance Land and Enrich Lives for more Filipinos. With a sharp focus on delivering quality products that are guided by our sustainability imperatives, we will continue to strive to build more spaces that enable communities and families to thrive,” ALI senior vice president, chief finance officer and treasurer Augusto D. Bengzon said.
ALI’s diverse portfolio spans residential, mall, office, hotel, resort and industrial logistics. Projects are spread across 53 estates nationwide.
For the first nine months of 2024, the company posted a 15 percent increase in net income, reaching P21.2 billion, alongside a 27 percent growth in consolidated revenues to P125.2 billion. Its property development revenues rose by 34 percent to P76.6 billion, driven by higher residential and commercial lot bookings.
ALI has also expanded its property portfolio by developing new estates like Southmont in Cavite and Centrala in Pampanga, both designed to respond to the needs of growing communities. Its industrial developments, such as the Batangas Technopark, provide platforms for economic activity and job generation.
ALI’s residential brand, Alveo Land, was named the “Best Residential Developer in the Philippines.” The company launched seven developments across 13 strategic locations and a reported P12.7 billion in gross take-up for the first quarter of 2024, representing a 29 percent year-on-year increase.
